HK1253249A1 - Novel phosphodiesterase type-5 inhibitor and application thereof - Google Patents

Novel phosphodiesterase type-5 inhibitor and application thereof

Info

Publication number
HK1253249A1
HK1253249A1 HK18112538.4A HK18112538A HK1253249A1 HK 1253249 A1 HK1253249 A1 HK 1253249A1 HK 18112538 A HK18112538 A HK 18112538A HK 1253249 A1 HK1253249 A1 HK 1253249A1
Authority
HK
Hong Kong
Prior art keywords
inhibitor
application
phosphodiesterase type
novel phosphodiesterase
novel
Prior art date
Application number
HK18112538.4A
Other languages
Chinese (zh)
Inventor
陳中祝
徐志剛
唐典勇
Original Assignee
重慶文理學院
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 重慶文理學院 filed Critical 重慶文理學院
Priority to HK18112538.4A priority Critical patent/HK1253249A1/en
Publication of HK1253249A1 publication Critical patent/HK1253249A1/en

Links

HK18112538.4A 2018-09-29 2018-09-29 Novel phosphodiesterase type-5 inhibitor and application thereof HK1253249A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HK18112538.4A HK1253249A1 (en) 2018-09-29 2018-09-29 Novel phosphodiesterase type-5 inhibitor and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HK18112538.4A HK1253249A1 (en) 2018-09-29 2018-09-29 Novel phosphodiesterase type-5 inhibitor and application thereof

Publications (1)

Publication Number Publication Date
HK1253249A1 true HK1253249A1 (en) 2019-06-14

Family

ID=69187466

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18112538.4A HK1253249A1 (en) 2018-09-29 2018-09-29 Novel phosphodiesterase type-5 inhibitor and application thereof

Country Status (1)

Country Link
HK (1) HK1253249A1 (en)

Similar Documents

Publication Publication Date Title
IL282487A (en) Tyk2 inhibitors and uses thereof
IL288381A (en) Tead inhibitors and uses thereof
IL288384A (en) Tead inhibitors and uses thereof
EP4034094A4 (en) Phosphodiesterase inhibitors and use
IL277794A (en) Atf6 inhibitors and uses thereof
IL283409A (en) Tyk2 inhibitors and uses thereof
IL282090A (en) Tyk2 inhibitors and uses thereof
SG11202107389SA (en) Hexone glucokinase inhibitor and use thereof
EP3572400C0 (en) Ezh2 inhibitor and use thereof
IL284799A (en) Tyk2 inhibitors and uses thereof
IL282350A (en) Rgmc-selective inhibitors and use thereof
HUE063120T2 (en) Lrrc33 inhibitors and use thereof
ZA202102192B (en) Fgfr4 inhibitor and use thereof
PT3712147T (en) Sglts inhibitor and application thereof
EP3784650A4 (en) Novel mct4 inhibitors and uses thereof
IL286622A (en) Prmt5 inhibitors and uses thereof
IL292198A (en) Tim-3 inhibitors and uses thereof
IL279276A (en) Erk inhibitor and use thereof
IL285595A (en) Spt5 inhibitors and uses thereof
IL280644A (en) Magnesium-serinate compound and use thereof
IL286485A (en) Pi4-kinase inhibitors and methods of using the same
IL291895A (en) Mcl1 inhibitors and uses thereof
IL283106A (en) Erk inhibitors and uses thereof
ZA202104192B (en) Mmpl3 inhibitors, compositions and uses thereof
IL280408A (en) Cdk inhibitors and uses thereof